SCHEMBL23927231

SCHEMBL23927231

O=C(F)C(=O)CC(F)(F)F

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA4 P22748 1/20 0.32
PLA2G4A P47712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3230536 0.75 OR51E2 (0.40) CA4
SCHEMBL92062 0.73
SCHEMBL6995141 0.73 CA1 (0.32) CA4
SCHEMBL4444683 0.73 CES1 (0.36) CA4
Fluoride SCHEMBL23927232 0.73 OR51E2 (0.38) CA4
SCHEMBL2392558 0.73 CA4 (0.36) CA4
SCHEMBL31203280 0.73 LDHA (0.33) CA4
SCHEMBL6990539 0.71 CASP1 (0.36)
SCHEMBL1058273 0.69 PLA2G4A (0.38) CA4PLA2G4A
SCHEMBL11352444 0.69 TDP1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113195466-B Method for stabilizing perfluoro (2-methylene-4-methyl-1, 3-dioxolane) -containing composition, and stabilized perfluoro (2-methylene-4-methyl-1, 3-dioxolane) -containing composition 东曹株式会社 2024-11-12 CN disclosed
US-11840522-B2 Method of stabilizing perfluoro(2-methylene-4-methyl-1,3-dioxolane) and composition containing stabilized perfluoro(2-methylene-4-methyl-1,3-dioxolane) TOSOH CORPORATION (JP) 2023-12-12 US disclosed
US-20220056006-A1 METHOD OF STABILIZING PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) AND COMPOSITION CONTAINING STABILIZED PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) TOSOH CORPORATION (JP) 2022-02-24 US disclosed
EP-3901144-A1 METHOD FOR STABILIZING PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE)-CONTAINING COMPOSITION AND STABILIZED PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE)-CONTAINING COMPOSITION Tosoh Corporation (JP) 2021-10-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11840522-B2 Method of stabilizing perfluoro(2-methylene-4-methyl-1,3-dioxolane) and composition containing stabilized perfluoro(2-methylene-4-methyl-1,3-dioxolane) FFAR4, AFF4, PYM1 CA4 2167/4885PLA2G4A 2161/4885
US-20220056006-A1 METHOD OF STABILIZING PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) AND COMPOSITION CONTAINING STABILIZED PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) FFAR4, AFF4, PYM1 CA4 2167/4885PLA2G4A 2161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.